---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-019359"
form_type: "8-K"
ticker: null
cik: "0001850838"
company_name: "Omega Therapeutics, Inc."
filed_at: "2025-02-03T23:59:59+00:00"
generated_at: "2026-05-27T04:07:28.899154+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 1.0
calibrated_materiality_score: 1.0
confidence: "high"
source: SEC EDGAR
---

# Omega Therapeutics enters RSA for Chapter 11, plans asset sale after loan default

## Summary
- Entered Restructuring Support Agreement with Flagship affiliate for $1.4M bridge loan and DIP loan to fund Chapter 11 process.
- Plans to file Chapter 11 by Feb 10, 2025; seeks Bankruptcy Court approval for stalking horse asset sale to Supporting Party.
- Received Nasdaq delisting notice for bid price below $1; has until July 28, 2025 to regain compliance.
- Loan from Banc of California terminated after default notice and setoff of $14.7M; company believes default not valid.
- Approved workforce reduction of up to 17 employees and retention bonuses for CEO ($40K) and CAO ($81.4K).

## SEC filing metadata
- accession: 0001193125-25-019359
- form_type: 8-K
- cik: 0001850838
- company_name: Omega Therapeutics, Inc.
- filed_at: 2025-02-03T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 1.0
- calibrated_materiality_score: 1.0
- confidence: high
- sec_items: 1.01, 1.02, 2.03, 3.01, 5.02, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1850838/000119312525019359/0001193125-25-019359-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1850838/000119312525019359/d927659d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-019359
- JSON: https://secwatch.observer/filing/0001193125-25-019359.json
- Plain text: https://secwatch.observer/filing/0001193125-25-019359.txt

## Source-grounded claims
- claim_id: ad378de7f5d1c163ab582bba9bb8e2e768283c94
  claim: Omega Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).
  evidence_excerpt: January 29, 2025, the Company received a written notice (the “Notice”) from The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that for the last 30 consecutive business days, the bid price for the Company’s co
  evidence_url: https://www.sec.gov/Archives/edgar/data/1850838/000119312525019359/0001193125-25-019359-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.